Vaxcyte, Inc.
| Security | PCVX / Vaxcyte, Inc. |
| Insider | Dhaliwal Harpreet S. |
This page shows the track record and history of Dhaliwal Harpreet S.
insider trades in Vaxcyte, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Dhaliwal Harpreet S. in PCVX / Vaxcyte, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Dhaliwal Harpreet S. in PCVX / Vaxcyte, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | 2025-09-08 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 32.4100 | -1,204 | -39 | 33,670 | ||||
| 2025-09-04 | 2025-09-02 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 31.5600 | -464 | -15 | 34,874 | ||||
| 2025-09-04 | 2025-09-02 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 31.5600 | -783 | -25 | 35,338 | ||||
| 2025-09-04 | 2025-09-02 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 31.5600 | -291 | -9 | 36,121 | ||||
| 2025-04-25 | 3 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 36,083 | ||||||||
| 2022-12-30 | 2022-12-28 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 25.0600 | 3,990 | 100 | 21,808 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 26.3800 | -1,513 | -40 | 16,890 | ||||
| 2022-03-04 | 2022-03-02 | 4 | Dhaliwal Harpreet S. | PCVX | Stock Option (right to buy) | D | 24.79 | 45,000 | 45,000 | |||||
| 2022-03-04 | 2022-03-02 | 4 | Dhaliwal Harpreet S. | PCVX | Common Stock | D | 17,500 | 17,500 | ||||||
| 2022-02-01 | 2021-11-08 | 4 | Dhaliwal Harpreet S. | PCVX | Stock Option (Right to Buy) | D | 25.06 | 100,000 | 100,000 | |||||
| 2021-10-06 | 3 | Dhaliwal Harpreet S. | PCVX | No securities owned. | D | 0 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
